MedTrace Logo

Growth, Safety and Tolerance of a Hydrolyzed Protein Infant Formula

NCT05618704 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2025-06-11

No results posted yet for this study

Summary

This is a single arm, open label, multicenter intervention trial to evaluate growth parameters, cow's milk related symptoms, gastrointestinal tolerance and safety in infants with cow's milk allergy receiving a hydrolyzed protein formula.

Conditions

  • Cow Milk Allergy

Interventions

DIETARY_SUPPLEMENT

Hydrolyzed protein infant formula

The subjects will take the formula for 16 weeks

Sponsors & Collaborators

  • Nutricia Research

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
0 Days
Max Age
8 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-16
Primary Completion
2024-10-14
Completion
2025-05-12

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05618704 on ClinicalTrials.gov